Using heart rate variability biofeedback to help with substance use disorder
A pilot study of ambulatory Heart Rate Variability Biofeedback for substance use disorder
This study is looking at how breathing exercises can help people recovering from substance use issues by making it easier for them to handle stress and cravings, so they can make better choices and stay motivated in their recovery journey.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10670398 on NIH RePORTER |
What this research studies
This research investigates how heart rate variability biofeedback (HRV BFB) can assist individuals recovering from substance use disorder (SUD) by improving their ability to manage stress and cravings. Participants will engage in rhythmic breathing exercises designed to enhance their physiological responses, which may help them resist urges to use alcohol or drugs. The study aims to provide immediate benefits in decision-making and motivation, potentially leading to better outcomes in recovery. By focusing on real-time interventions, this approach seeks to address the challenges faced during early recovery from SUD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals in early recovery from substance use disorder, particularly those struggling with alcohol or drug cravings.
Not a fit: Patients who are not currently experiencing substance use issues or are not in recovery may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new, effective tool for individuals in recovery from substance use disorder to manage cravings and improve their coping strategies.
How similar studies have performed: Previous studies have shown promising results with heart rate variability biofeedback in improving behavioral outcomes, suggesting potential for success in this novel application for substance use disorder.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Eddie, David — Massachusetts General Hospital
- Study coordinator: Eddie, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.